期刊
CLINICAL CHEMISTRY
卷 53, 期 10, 页码 1820-1826出版社
OXFORD UNIV PRESS INC
DOI: 10.1373/clinchem.2007.091629
关键词
-
Background: We recently described a holographic optical sensor with improved selectivity for glucose over fructose that was based on a thin-film polymer hydro ' gel containing phenylboronic acid receptors. The aim of the present work was to measure glucose in human blood plasma as opposed to simple buffers and track changes in concentration at a rate mimicking glucose changes in vivo. Methods: We used holographic sensors containing acrylamide, NN'-methylenebisacrvlamide, 3-acrylamidophenylboronic acid, and (3-acrylamidopropyl)trimethylammonium chloride to measure 7 human blood plasma samples at different glucose concentrations (3-33 mmol/L) in static mode. Separately, using a flow cell, the glucose concentration was varied at approximately 0.17-0.28 mmol(-1) - L-1 - min(-1), and the sensor's ability to continuously monitor glucose was investigated over an extended period. Results: We subjected the results of the ex vivo static measurements to error grid analysis. Of 46 measurements, 42 (91.3%) fell in zone A of a Clarke error grid, and the remainder (8.7%) fell in zone B. The ex vivo flow experiments showed that the sensor is able to accurately track changes in concentration occurring in real time without lag or evidence of hysteresis. Conclusions: We demonstrate the ability of a phenylboronic acid-based sensor to measure glucose in human blood plasma for the 1st time in vitro. Holographic glucose sensors can be used without recourse to recalibration. Their robust nature, coupled with their format flexibility, makes them an attractive alternative to con-ventional electrochemical enzyme-based methods of glucose monitoring for people with diabetes. (c) 2007 American Association for Clinical Chemistry.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据